Want to join the conversation?
$GRMN 2Q15 Q&A: Charles from Dougherty long-term target operating margin in fitness, and Doug said, I think it's probably more complicated when than just looking at differences between what it was before Trackers & what it was after. Keep in mind that we are facing a significant headwind due to the currency issue, so that's the major factor as well
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.